ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,482, issued on Jan. 27, was assigned to Stamford Devices Ltd. (Galway, Ireland).

"Aerosolised medication of ventilated patients with minimised dead volume" was invented by Stefan Kern (Elsenfeld, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "A coupling part with integrated aerosol generator for use in a breathing circuit, comprising a housing (10) enclosing a cavity (V), having a first opening at a first end prepared for direct or indirect connection to a ventilator, a second opening at a second end, which is suitable for direct or indirect connection to a patient line or an endotracheal tube, wherein an aerosol generator (20) is integrated...